Keva Health’s digital platform leverages leading clinical research in the field of pulmonary care to improve patient’s health outcomes.
Read more:
Spirometry Utilization Among Patients with Asthma (2020)
Diagnosis and early detection of COPD using spirometry (2014)
Read more:
Impact of a digital health intervention on asthma resource utilization
(2018)
Remote FEV1 Monitoring in Asthma Patients: A Pilot Study (2020)
Home self-monitoring in patients with asthma using a mobile spirometry system (2020)
Read more:
Exploring the potential benefits of digital health technology for the management of COPD (2019)
Remote Patient Monitoring for the Detection of COPD Exacerbations (2020)
Read more:
Home monitoring improves endpoint efficiency in idiopathic pulmonary fibrosis (2016)
Read more:
No money or other consideration is being solicited, and if sent in response, will not be accepted. No offer to buy the securities can be accepted and no part of the purchase price can be received until the offering statement is filed and only through an intermediary’s platform. An indication of interest involves no obligation or commitment of any kind. “reserving” securities is simply an indication of interest.